CAS 16409-34-0|Glycodeoxycholate Sodium
| Common Name | Glycodeoxycholate Sodium | ||
|---|---|---|---|
| CAS Number | 16409-34-0 | Molecular Weight | 472.61 |
| Density | 0.9330g/cm3 | Boiling Point | 655.6ºC at 760 mmHg |
| Molecular Formula | C26H43NNaO5 | Melting Point | 207 °C |
| MSDS | ChineseUSA | Flash Point | 350.3ºC |
Names
| Name | Glycodeoxycholic acid sodium salt |
|---|---|
| Synonym | More Synonyms |
Glycodeoxycholate Sodium BiologicalActivity
| Description | Glycodeoxycholate Sodium is a bile salt. |
|---|---|
| Related Catalog | Research Areas >>Metabolic DiseaseNatural Products >>Steroids |
| Target | Human Endogenous Metabolite |
Chemical & Physical Properties
| Density | 0.9330g/cm3 |
|---|---|
| Boiling Point | 655.6ºC at 760 mmHg |
| Melting Point | 207 °C |
| Molecular Formula | C26H43NNaO5 |
| Molecular Weight | 472.61 |
| Flash Point | 350.3ºC |
| PSA | 109.69000 |
| LogP | 2.65030 |
| Vapour Pressure | 5.74E-20mmHg at 25°C |
| InChIKey | IIYSTUUVIASHBG-YEUHZSMFSA-N |
| SMILES | CC(CCC(=O)NCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C.[Na] |
| Storage condition | 2-8℃ |
Safety Information
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3.0 |
Articles14
More Articles| Functional role of oppA encoding an oligopeptide-binding protein from Lactobacillus salivarius Ren in bile tolerance. J. Ind. Microbiol. Biotechnol. 42 , 1167-74, (2015) Lactobacillus salivarius is a member of the indigenous microbiota of the human gastrointestinal tract (GIT), and some L. salivarius strains are considered as probiotics. Bile tolerance is a crucial pr... | |
| Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans. Drug Metab. Dispos. 43 , 851-63, (2015) Inhibition of hepatic transporters such as organic anion transporting polypeptides (OATPs) 1B can cause drug-drug interactions (DDIs). Determining the impact of perpetrator drugs on the plasma exposur... | |
| Mechanisms of cholesterol and saturated fatty acid lowering by Quillaja saponaria extract, studied by in vitro digestion model. Food Funct. 6 , 1319-30, (2015) Quillaja saponin extracts are known to reduce plasma cholesterol levels in humans. Here we study the mechanism of this effect with Quillaja Dry saponin extract (QD). In vitro model of triglyceride lip... |
Synonyms
| 2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid,sodium |
| 3α,12α-Dihydroxy-5β-cholan-24-oic acid N-(carboxymethyl)amide |
| Glycodesoxycholic acid |
| N-(3α,12α-Dihydroxy-24-oxocholan-24-yl)glycine |
| EINECS 240-455-4 |
| Sodium glycodeoxycholate |
| MFCD00036742 |
